Florence Leroux

1.7k total citations
42 papers, 876 citations indexed

About

Florence Leroux is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Florence Leroux has authored 42 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Infectious Diseases and 9 papers in Organic Chemistry. Recurrent topics in Florence Leroux's work include Cancer therapeutics and mechanisms (8 papers), Tuberculosis Research and Epidemiology (8 papers) and Computational Drug Discovery Methods (8 papers). Florence Leroux is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Tuberculosis Research and Epidemiology (8 papers) and Computational Drug Discovery Methods (8 papers). Florence Leroux collaborates with scholars based in France, Belgium and United States. Florence Leroux's co-authors include Benoît Déprez, Rebecca Deprez‐Poulain, Catherine Piveteau, Nicolas Willand, Alain R. Baulard, Olivier Spérandio, Marion Flipo, Bruno O. Villoutreix, Vincent Villeret and Julie Charton and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Medicine and International Journal of Molecular Sciences.

In The Last Decade

Florence Leroux

39 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Leroux France 15 502 263 200 167 138 42 876
Luís Fernando Saraiva Macedo Timmers Brazil 16 558 1.1× 214 0.8× 156 0.8× 203 1.2× 97 0.7× 68 908
Fabio Zuccotto United Kingdom 15 591 1.2× 165 0.6× 361 1.8× 153 0.9× 275 2.0× 25 1.1k
Rafael Andrade Caceres Brazil 17 593 1.2× 156 0.6× 111 0.6× 253 1.5× 95 0.7× 39 1.0k
Denise A. Rozwarski United States 9 673 1.3× 440 1.7× 305 1.5× 129 0.8× 249 1.8× 9 1.3k
Shalini Saxena India 17 403 0.8× 298 1.1× 307 1.5× 128 0.8× 89 0.6× 32 704
Yaxue Zhao China 17 782 1.6× 104 0.4× 161 0.8× 70 0.4× 106 0.8× 44 1.2k
Claudia Jessen‐Trefzer Germany 13 497 1.0× 205 0.8× 189 0.9× 47 0.3× 103 0.7× 24 734
Anil Mistry United States 10 456 0.9× 89 0.3× 312 1.6× 73 0.4× 67 0.5× 10 840
George A. Garcia United States 22 1.1k 2.1× 279 1.1× 124 0.6× 72 0.4× 153 1.1× 67 1.5k
S.K. Palaninathan United States 16 762 1.5× 197 0.7× 219 1.1× 83 0.5× 90 0.7× 17 1.3k

Countries citing papers authored by Florence Leroux

Since Specialization
Citations

This map shows the geographic impact of Florence Leroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Leroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Leroux more than expected).

Fields of papers citing papers by Florence Leroux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Leroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Leroux. The network helps show where Florence Leroux may publish in the future.

Co-authorship network of co-authors of Florence Leroux

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Leroux. A scholar is included among the top collaborators of Florence Leroux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Leroux. Florence Leroux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gealageas, Ronan, François‐Xavier Mauvais, Nathalie Azaroual, et al.. (2025). Discovery of New Nanomolar Selective IRAP Inhibitors. Journal of Medicinal Chemistry. 68(4). 4168–4195.
2.
Landry, Valérie, Lowiese Desmarets, François‐Xavier Cantrelle, et al.. (2024). N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease. European Journal of Medicinal Chemistry. 276. 116707–116707. 1 indexed citations
3.
Dumont, Julie, Virginie Vauthier, Julie Charton, et al.. (2024). Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach. Communications Biology. 7(1). 898–898. 1 indexed citations
4.
Landry, Valérie, Pascal Roussel, Catherine Piveteau, et al.. (2023). Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis. International Journal of Molecular Sciences. 24(24). 17395–17395. 1 indexed citations
5.
Piveteau, Catherine, Florence Leroux, Stéphanie Slupek, et al.. (2023). Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals. 16(3). 335–335. 2 indexed citations
6.
Jiménez-Castellanos, Juan-Carlos, Elizabeth Pradel, Catherine Piveteau, et al.. (2023). Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump. European Journal of Medicinal Chemistry. 259. 115630–115630. 6 indexed citations
7.
Jiménez-Castellanos, Juan-Carlos, Laurye Van Maele, Elizabeth Pradel, et al.. (2023). Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Molecular Medicine. 16(1). 93–111. 12 indexed citations
8.
Hanoulle, Xavier, Valérie Landry, Danai Moschidi, et al.. (2023). Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses. European Journal of Medicinal Chemistry. 250. 115186–115186. 12 indexed citations
9.
Wen, Xiaoan, Valérie Landry, Adrien Herlédan, et al.. (2021). Identification of indole-based activators of insulin degrading enzyme. European Journal of Medicinal Chemistry. 228. 113982–113982. 7 indexed citations
10.
Cantrelle, François‐Xavier, Emmanuelle Boll, Danai Moschidi, et al.. (2021). NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment. Angewandte Chemie International Edition. 60(48). 25428–25435. 30 indexed citations
11.
Cantrelle, François‐Xavier, Emmanuelle Boll, Danai Moschidi, et al.. (2021). NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment. Angewandte Chemie. 133(48). 25632–25639. 1 indexed citations
12.
Chaput, Ludovic, et al.. (2020). High-Throughput Image-Based Aggresome Quantification. SLAS DISCOVERY. 25(7). 783–791. 7 indexed citations
13.
Herlédan, Adrien, Florence Leroux, Catherine Piveteau, et al.. (2019). Drug Target Engagement Using Coupled Cellular Thermal Shift Assay—Acoustic Reverse-Phase Protein Array. SLAS DISCOVERY. 25(2). 207–214. 9 indexed citations
14.
Kemmer, Christian, Adrien Herlédan, Rosangela Frita, et al.. (2019). A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. European Journal of Medicinal Chemistry. 167. 426–438. 14 indexed citations
15.
Leroux, Florence, Damien Bosc, Terence Beghyn, et al.. (2019). Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European Journal of Medicinal Chemistry. 179. 557–566. 13 indexed citations
16.
Eccles, Richard, et al.. (2018). Postal Services: Survey of Competition Law Developments: 2017. Journal of European Competition Law & Practice. 9(5). 343–348.
17.
Mathieu, Anne‐Laure, Olivier Spérandio, Adrien Herlédan, et al.. (2014). Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737. SLAS DISCOVERY. 19(7). 1035–1046. 12 indexed citations
18.
Willand, Nicolas, Xavier Carette, Pablo Bifani, et al.. (2009). Synthetic EthR inhibitors boost antituberculous activity of ethionamide. Nature Medicine. 15(5). 537–544. 138 indexed citations
19.
Goossens, Jean‐François, Florence Leroux, Nicole Pommery, Jean Pommery, & Jean‐Pierre Hénichart. (1994). High-performance liquid chromatographic determination of cyclic 3′,5′-AMP with fluorescence detection vasoactive intestinal peptide-induced modification of its concentration in neuroblastoma cells. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 192–196. 5 indexed citations
20.
Leroux, Florence, Jean‐François Goossens, Nicole Pommery, & Jean‐Pierre Hénichart. (1994). A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells. Regulatory Peptides. 52(2). 119–128. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026